Largest biotech companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Moderna has the lowest figure of the 24 biotech companies ranked by earnings, at -CZK 62.7B, followed by BioNTech (-CZK 28B) and Revolution Medicines (-CZK 25.1B). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Moderna-CZK 62.7B
- Median
- -CZK 1.5B
- Combined market value
- CZK 18.71T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | -CZK 62.7B | CZK 1.82T | CZK 4,506.40 | 1.91% down | 755% up | ||
| 2 | BioNTechBNTX · Health Care | -CZK 28B | CZK 463.7B | CZK 1,870.37 | 0.79% down | 16% down | ||
| 3 | Revolution MedicinesRVMD · Health Care | -CZK 25.1B | CZK 768.9B | CZK 3,554.89 | 1.64% down | 131% up | ||
| 4 | VaxcytePCVX · Health Care | -CZK 17B | CZK 207.6B | CZK 1,311.74 | 0.60% down | 22% up | ||
| 5 | CRISPR TherapeuticsCRSP · Health Care | -CZK 12.9B | CZK 90.7B | CZK 934.85 | 4.81% up | 21% down | ||
| 6 | ImmunovantIMVT · Health Care | -CZK 11.2B | CZK 154.6B | CZK 747.12 | 1.26% up | 43% up | ||
| 7 | Scholar Rock HoldingSRRK · Health Care | -CZK 8.4B | CZK 128.3B | CZK 1,051.71 | 5.01% up | 14% up | ||
| 8 | ImmunityBioIBRX · Health Care | -CZK 7.8B | CZK 159.1B | CZK 149.51 | 7.51% up | 193% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | -CZK 6.9B | CZK 231.9B | CZK 2,716.79 | 0.63% up | 87% up | ||
| 10 | Kodiak SciencesKOD · Health Care | -CZK 5.1B | CZK 141.9B | CZK 2,170.07 | 0.91% up | 396% up | ||
| 11 | CG OncologyCGON · Health Care | -CZK 3.6B | CZK 161.9B | CZK 1,812.94 | 3.38% up | 85% up | ||
| 12 | Twist BioscienceTWST · Health Care | -CZK 1.7B | CZK 178.4B | CZK 2,616.60 | 5.16% up | 340% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | -CZK 1.3B | CZK 103.1B | CZK 636.93 | 0.63% up | 88% up | ||
| 14 | RepligenRGEN · Health Care | CZK 1.1B | CZK 245B | CZK 3,832.70 | 6.38% up | 5% up | ||
| 15 | Bio-TechneTECH · Health Care | CZK 4B | CZK 254B | CZK 1,616.88 | 0.21% up | 26% up | ||
| 16 | Krystal BiotechKRYS · Health Care | CZK 4.6B | CZK 206.7B | CZK 6,974.71 | 5.16% up | 46% up | ||
| 17 | Halozyme TherapeuticsHALO · Health Care | CZK 7B | CZK 245B | CZK 2,148.51 | 0.77% up | 37% up | ||
| 18 | QiagenQGEN · Health Care | CZK 9.4B | CZK 227.7B | CZK 1,102.80 | 0.22% down | 12% up | ||
| 19 | Neurocrine BiosciencesNBIX · Health Care | CZK 10.6B | CZK 365.6B | CZK 3,611.66 | 2.02% down | 20% up | ||
| 20 | ExelixisEXEL · Health Care | CZK 17.4B | CZK 375B | CZK 1,536.90 | 0.99% up | 63% up | ||
| 21 | argenxARGX · Health Care | CZK 28.7B | CZK 1.32T | CZK 21,018.78 | 0.15% down | 4% up | ||
| 22 | BiogenBIIB · Health Care | CZK 28.7B | CZK 827.7B | CZK 5,599.10 | 0.49% up | 49% up | ||
| 23 | AmgenAMGN · Health Care | CZK 171.3B | CZK 5.37T | CZK 9,918.56 | 2.50% down | 34% up | ||
| 24 | Gilead SciencesGILD · Health Care | CZK 189.1B | CZK 4.66T | CZK 3,760.84 | 0.57% down | 33% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2160 CZK).
Questions and answers
Which biotech companies have the lowest earnings?
Moderna (-CZK 62.7B), BioNTech (-CZK 28B) and Revolution Medicines (-CZK 25.1B) have the lowest earnings of the 24 biotech companies ranked here as of 18 Nov 2026, 17:47 UTC.
How many biotech companies are in this ranking?
24 are ranked by earnings.
What are these biotech companies worth together?
The 24 biotech companies ranked by earnings have a combined market value of CZK 18.71T as of 18 Nov 2026, 17:47 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.